A Patient with Acquired Pure Red Cell Aplasia Showing a Positive Antiglobulin Test and the Presence of Inhibitor against Erythroid Precursors.

DOI Web Site Web Site PubMed 被引用文献1件 参考文献18件
  • OKOSHI Yasushi
    Division of Hematology, Institute of Clinical Medicine, University of Tsukuba
  • IMAGAWA Shigehiko
    Division of Hematology, Institute of Clinical Medicine, University of Tsukuba
  • HIGUCHI Masato
    Chugai Pharmaceutical Co., Ltd.
  • YOSHIDA Chikashi
    Division of Hematology, Institute of Clinical Medicine, University of Tsukuba
  • SHIMIZU Seiichi
    Division of Hematology, Institute of Clinical Medicine, University of Tsukuba
  • MUKAI Harumi Y
    Division of Hematology, Institute of Clinical Medicine, University of Tsukuba
  • KOMENO Takuya
    Division of Hematology, Institute of Clinical Medicine, University of Tsukuba
  • HASEGAWA Yuichi
    Division of Hematology, Institute of Clinical Medicine, University of Tsukuba
  • NINOMIYA Haruhiko
    Division of Hematology, Institute of Clinical Medicine, University of Tsukuba
  • KOJIMA Hiroshi
    Division of Hematology, Institute of Clinical Medicine, University of Tsukuba
  • NAGASAWA Toshiro
    Division of Hematology, Institute of Clinical Medicine, University of Tsukuba

書誌事項

タイトル別名
  • Patient with Acquired Pure Red Cell Aplasia Showing a Positive Antiglobulin Test and the Presence of Inhibitor against Erythroid Precursors

この論文をさがす

抄録

A 66-year-old Japanese man developed severe anemia and erythroid hypoplasia in bone marrow without any significant underlying disease. The results of an antiglobulin test were strongly positive, and serum erythropoietin (Epo) was high. The patient was diagnosed as having acquired pure red cell aplasia (PRCA) and was treated with steroids. Anemia was subsided by reticulocyte production in parallel with a decrease in the titer of antiglobulin test and the level of Epo. We studied the immunological mechanism directed against erythroid cells in vitro by using the patient's serum. In vitro analysis indicated the presence of an inhibitor of erythroid precursors at onset, and its disappearance at remission, suggesting the presence of inhibitor against erythroid precursors.<br>(Internal Medicine 41: 589-592, 2002)

収録刊行物

  • Internal Medicine

    Internal Medicine 41 (7), 589-592, 2002

    一般社団法人 日本内科学会

被引用文献 (1)*注記

もっと見る

参考文献 (18)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ